EnLiSense has a total of 7 patents globally, out of which 2 have been granted. Of these 7 patents, more than 85% patents are active. The United States of America is where EnLiSense has filed all their patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of EnLiSense.
EnLiSense was founded in 2014. EnLiSense provides wearable diagnostic tools for assessing sweat biomarkers. It helps in the diagnosis of cardiovascular illnesses as well as the non-invasive monitoring of blood glucose. It provides applications for point-of-care, ambulatory, and home settings for the diagnostic and prognostic assessment of infectious and chronic illnesses.
Do read about some of the most popular patents of EnLiSense which have been covered by us in this article and also you can find EnLiSense patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over EnLiSense patent portfolio.
How many patents does EnLiSense have?
EnLiSense has a total of 7 patents globally. These patents belong to 6 unique patent family. Out of 7 patents, 6 patents are active.
How Many Patents did EnLiSense File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | EnLiSense Applications Filed | EnLiSense Patents Granted |
2023 | – | 1 |
2021 | 2 | – |
2019 | 1 | – |
2018 | 1 | 1 |
2017 | 2 | – |
2015 | 1 | – |
How many EnLiSense patents are Alive/Dead?
How Many Patents did EnLiSense File in Different Countries?
EnLiSense filled all their patents in United States of America.
Countries in which Envisagenics Filed Patents
Country | Patent |
United States of America | 7 |
Where are Research Centers of EnLiSense Patents Located?
The Research Center of EnLiSense Patents is the United States of America.
Best EnLiSense Patents
WO2018075824A1 is the most popular patent in the EnLiSense portfolio. It has received 6 citations so far from companies like Medtronic, InnoTech Precision Medicine, Cardiai Technologies.
Below is the list of 10 most cited patents of EnLiSense:
Publication Number | Citation Count |
WO2018075824A1 | 6 |
US10006882B2 | 3 |
US20210325380A1 | 3 |
US20200054259A1 | 2 |
US20190069818A1 | 2 |
US20220160265A1 | 1 |
List of EnLiSense Patents
EnLiSense Patent | Title |
US11782055B2 | Multi-Configurable Sensing Array And Methods Of Using Same |
US10006882B2 | Biosensing System And Methods Using Electron-Ionic Mechanisms At Fluid-Sensor Interfaces |
US20220160265A1 | Machine-Learning Based Biosensor System |
US20210325380A1 | Disease Diagnostics Using A Multi-Configurable Sensing Array |
US20200054259A1 | High Density Analog Multipexing |
US20190069818A1 | Wearable Biosensors With Room Temperature Ionic Liquid Buffer |
WO2018075824A1 | Multi-Configurable Sensing Array And Methods Of Using Same |
What are EnLiSense key innovation segments?
What Technologies are Covered by EnLiSense?
The chart below distributes patents filed by EnLiSense